The differentiation and activation of immune cells is associated with changes in the 5 2 expression of hundreds to thousands of genes (1, 2) . Genes specifically expressed by a cell any other factor, the RMA normalised data was loaded into the network analysis tool Miru clustered based on cell type rather than study ( Figure S4 ). For blood and tissue datasets, the 1 0 8
data was collapsed to one probe-set per gene by choosing the probe-set with the highest 1 0 9 variance across samples. datasets were pre-processed as described above. A number of transcriptomic profiles derived 1 7 3 from RNA-seq technology were also analysed by ImSig to ensure its wide applicability and 1 7 4 lack of platform dependency, in particular RNA-seq data were downloaded from TCGA In order to facilitate the use of ImSig a scoring system was devised that supports the 1 7 8
identification of any given signature without the need to perform network analysis. For any 1 7 9
given transcriptomic dataset, the calculation of the ImSig scores is a two-step process where 1 8 0 an initial score is first computed based on the following formula:
Where r is the correlation cut-off and i is the cell type/pathway signature. edges is calculated with [n*(n-1)]/2, where n is the number of genes in any given signature. The maximum possible nodes is the number of genes defining a particular ImSig signature.
The initial score is computed for all eight cell type clusters (B cells, T cells, monocytes, 1 9 0 macrophages, NK cells, neutrophils, plasma cells, platelets) and three pathway clusters (cell 1 9 1 division, protein translational and interferon response) using a range of Pearson correlation 1 9 2 coefficient thresholds, from 0.50 to 0.99 at 0.01 intervals. The resulting matrix contains 50 1 9 3 scores for each of the signature. At this point we set an 'initial score threshold' of 20 and 10 1 9 4
for microarray and RNA-seq datasets, respectively (these were determined empirically, 1 9 5 Figure 2B&C ). Any value below this threshold is not regarded to be a genuine cluster due to 1 9 6 a poor correlation between genes within the signature at the set r-value. We recommend these 1 9 7
thresholds as they are based on observations from numerous datasets. Following this the final 1 9 8
ImSig score is calculated for each cluster using the following formula. All data should be in log scale for calculating ImSig score. An R script is available for 2 0 1
running ImSig scoring algorithm. The script can be downloaded here: is a value between 0 and 1. After extensive evaluation, any value above 0.3 is regarded as 2 0 4 evidence that the cell type/pathway signature is present in the dataset. groups. variance T-test showed a significant alteration in cell counts between these two group of to make up the parent cell type (T cells, B cells, neutrophils, NK cells). Then, each cell type
was normalised independently to be represented as a fraction of 1 across samples (i.e., the 2 2 1 sum of normalised cell proportion for any cell type is equal to 1). Similarly, for ImSig the 2 2 2 relative abundance of immune cells were calculated by averaging the expression of signature unequal variance T-test was then used to test for significant change in cell proportions 2 2 5 between the two groups of patients in all four cell types. Similarly, a tissue dataset (trachoma: GSE20436) was downloaded. The patients were divided 2 2 7
into three groups as per the level of infectivity according to its authors (controls, symptom 2 2 8 +ve/C. trachomatis -ve patients, and symptom +ve/C. trachomatis +ve patients). As CIBERSORT and ImSig. This was followed by a one-way analysis of variance (ANOVA) to 2 3 2 test for significant changes in cell numbers between the three groups of patients. Blood and tissue immune signatures (ImSig blood/tissue ) 2 3 7
ImSig was derived as described in the experimental procedures, and as shown in (Figure 1 ).
3 8
Briefly, an initial meta-analysis was carried out on 330 samples of isolated human immune 2 3 9 cell populations and the top 100 differentially expressed genes were determined for each 2 4 0 immune cell type. Using a network-based approach to identify sets of robustly co-expressed 2 4 1 (correlated) genes in a variety of blood datasets, the lists were further refined (Figure 2A ).
4 2
The resulting cell-specific marker gene lists were collectively named ImSig blood . However, the transcriptomic datasets, where the cell-based marker genes showed independent expression.
4 5
To overcome this issue we identified the most conserved cell type-specific groups of genes 2 4 6
based on their co-expression across four tissue datasets, and further refined them by 2 4 7 examining a eight other tissue datasets (Figure 2A ). This resulted in our ImSig tissue gene the genes comprising these signatures and numbers for each cell type or pathway see Table   2 5 2 S1. GO term analysis confirmed that the cell marker lists for both ImSig signatures were 2 5 3 highly enriched in genes related to immune function (Table S2, S3 ). The overlap between 2 5 4 blood and tissue signature varied depending on cell type/pathway ( Figure S3 ).
5 5
Genes that make up the signatures 2 5 6 Table S1 highlights the sets of genes that distinguish ImSig blood and ImSig tissue . The process known to be macrophage-specific and essential for differentiation and survival (15), and also 2 7 2 contains many of the genes that are up-regulated in monocyte-derived macrophages derived 2 7 3 by cultivation in CSF1 (16). An unexpected member of this cluster is CD4. In blood, CD4 is 2 7 4 expressed at similar levels in CD4+ T cells and monocytes, and so does not form part of a T 2 7 5 cell cluster. In tissue, CD4 is highly-expressed by macrophages, and correlates more highly with their presence than with the presence of T cells. The clusters annotated provisionally as 2 7 7 monocyte and neutrophil have very little overlap between the blood and tissue profiles. Archetypal markers, CD14 for monocytes and the G-CSF receptor and chemokine receptor 2 7 9 CXCR2 (the receptor for IL8) are co-expressed with very different gene sets in blood and 2 8 0
tissues. Hence, it may be more appropriate to consider distinct separate myelomonocytic 2 8 1 regulons, reflecting the rapid differentiation of these cells following extravasation. For example, S100A8/A9, which encode the most abundant neutrophil proteins (17), are also The ImSig scoring algorithm was developed to reflect the correlation and expression level of is required for an accurate representation analysis. Being correlation-based, a dataset 3 0 0 generally needs to comprise of at least 20 distinct samples is needed to provide sufficient 3 0 1 diversity before the ImSig algorithm can be applied.
0 2
Validation of blood and tissue marker genes
To test its universality, we applied ImSig blood to deconvolution of a range transcriptomics data monocytes and neutrophils ( Figure S1A ). In terms of the average expression of marker genes, with type 1 diabetes mellitus (GSE55098) identified increased proliferation in a number of 3 1 2 samples ( Figure 3A ) and the analysis also clearly identified the presence of T cells, B cells, 3 1 3 along with plasma cells, monocytes, neutrophils, NK cells and platelets (Table S4) . Notably there was also significantly lower expression (p=1E-10) of the NK cells markers genes in 3 1 5 samples derived type 1 diabetes ( Figure 3A) where these cells are known to be dysregulated 3 1 6 (18, 19).
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To validate ImSig tissue , we first examined a dataset of triple-negative breast cancers derived neutrophils and NK cells present in these samples ( Figure 3B ). The levels of all immune cells 3 2 3 (as judged by the average expression of the marker genes) varied greatly between samples.
2 4
By contrast, a relatively small brain tumour dataset comprising 23 samples of primitive other than an NK signature ( Figure S1B) . Being behind the blood-brain barrier, lymphocyte 3 2 7
populations in these tumours are likely absent or at very low levels (21) but infiltration of T 3 2 8 cells was evident in other brain tumour datasets that we have analysed (Table S4) . Neutrophil Figure 5A , Table S7 ). Samples from the trachoma dataset were divided into three groups of 3 5 0 20, based on the level of infection as originally described (for more detail see Methods). Although actual cell counts are not available for these data, it is known that the immune 3 5 2 infiltrate increases with the level of infection (27). ImSig tissue showed there to be a significant Table S7 ). Moreover, the pattern observed using CIBERSORT did not seem to correlate with the infection status of C. trachomatis ( Figure 5B ). CIBERSORT was also used in its native 
